Show simple item record

dc.creatorRoa E,Iván
dc.creatorMelo,Angélica
dc.creatorRoa S,Juan
dc.creatorAraya O,Juan
dc.creatorVillaseca H,Miguel
dc.creatorde Aretxabala U,Xabier
dc.date2000-03-01
dc.date.accessioned2019-05-02T21:10:45Z
dc.date.available2019-05-02T21:10:45Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000300001
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/81077
dc.descriptionBackground: Gallbladder cancer frequency and mortality renders it one of the most important neoplastic diseases in Chile. P53 tumor suppressor gene has been studied in most types of cancer, but there is scarce information about it in gallbladder cancer. Aim: To study the frequency of P53 gene mutation in gallbladder cancer in the ninth region of Chile. Material and methods: In 25 pathological samples of gallbladder cancer, the direct amplification and sequencing of p53 gene exons 5,6,7,8-8 was possible. Results: Seventeen punctual mutations were observed in 13 cases (52%). There were 10 transitions, 5 transversions, one insertion (codon 194) and one deletion (codon 186). Eight cases had mutations in exon 5, six had mutations in exon 6, two had mutations in exon 7 and one had mutations in exons 8-9. In 14 of 25 cases, gene p53 protein was positive. When immunohistochemical expression of gene p53 protein was positive in more than 20% of cells, there was a high correlation between genetic alterations and immunohistochemical expression of the protein, with a specificity, sensitivity, positive and negative predictive values over 80%. Conclusions: P53 gene mutation is observed in a high proportion of gallbladder cancers at it can be accurately detected with conventional immunohistochemical techniques. The importance of this gene in the genesis of this carcinoma should be determined studying preneoplastic lesions and early carcinomas
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.relation10.4067/S0034-98872000000300001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista médica de Chile v.128 n.3 2000
dc.subjectGallbladder neoplasms
dc.subjectGenes Suppressor
dc.subjecttumor
dc.subjectImmunohistochemistry
dc.titleMutación del gen p53 en el cáncer de la vesícula biliar


This item appears in the following Collection(s)

Show simple item record